Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Geron (GERN) Shares Outstanding (Diluted Average) (2020 - 2025)

Geron's Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $666.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 3.19% year-over-year to $666.7 million; the TTM value through Dec 2025 reached $666.7 million, up 3.19%, while the annual FY2025 figure was $666.7 million, 3.19% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $666.7 million at Geron, roughly flat from $667.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $667.1 million in Q3 2025 and bottomed at $327.0 million in Q2 2021.
  • The 5-year median for Shares Outstanding (Diluted Average) is $562.4 million (2023), against an average of $523.0 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) soared 63.96% in 2023 before it grew 0.75% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $327.6 million in 2021, then rose by 16.22% to $380.8 million in 2022, then skyrocketed by 49.86% to $570.6 million in 2023, then grew by 13.21% to $646.0 million in 2024, then grew by 3.19% to $666.7 million in 2025.
  • Per Business Quant, the three most recent readings for GERN's Shares Outstanding (Diluted Average) are $666.7 million (Q4 2025), $667.1 million (Q3 2025), and $666.0 million (Q2 2025).